Financhill
Back

SPDR® S&P Health Care Services ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison

Sell
50

XHS
SPDR® S&P Health Care Services ETF

Last Price:
96.67
Seasonality Move:
6.32%
Buy
63

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.58
Seasonality Move:
8.86%
Sell
50
SPDR® S&P Health Care Services ETF (XHS) is a Sell

Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Health Care Services ETF [XHS] share price is $97.55. The Score for XHS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • XHS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XHS Stock Price Chart

What is SPDR® S&P Health Care Services ETF's stock price today?

  • The SPDR® S&P Health Care Services ETF share price today is $97.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XHS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $15.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.

XHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 60.73 Buy
Chaikin Money Flow: 3111 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93 - 95.88) Buy
Bollinger Bands (100): (92.05 - 97.61) Buy

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 59.34 Buy
Chaikin Money Flow: -127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.63 - 15.23) Buy
Bollinger Bands (100): (14 - 15.38) Buy

XHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.27 Buy
20-day SMA: 94.69 Buy
50-day SMA: 95.65 Buy
200-day SMA: 92.48 Buy
8-day EMA: 94.73 Buy
20-day EMA: 94.64 Buy
50-day EMA: 95.01 Buy
200-day EMA: 92.9 Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.03 Buy
20-day SMA: 15 Buy
50-day SMA: 15.01 Buy
200-day SMA: 15.06 Buy
8-day EMA: 15.09 Buy
20-day EMA: 15.01 Buy
50-day EMA: 14.94 Buy
200-day EMA: 14.59 Buy

SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SPDR® S&P Health Care Services ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):